Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.45B |
| 2 |
Visa
V
|
+$1.05B |
| 3 |
Microsoft
MSFT
|
+$1.01B |
| 4 |
Apple
AAPL
|
+$578M |
| 5 |
Norfolk Southern
NSC
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.24B |
| 2 |
McDonald's
MCD
|
+$707M |
| 3 |
JPMorgan Chase
JPM
|
+$680M |
| 4 |
Texas Instruments
TXN
|
+$678M |
| 5 |
Edwards Lifesciences
EW
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.8% |
| 2 | Healthcare | 2.66% |
| 3 | Financials | 2.38% |
| 4 | Consumer Discretionary | 2.05% |
| 5 | Industrials | 2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11926
PUT
Aldeyra Therapeutics
ALDX
$96.5M
| $80.9K | ﹤0.01% |
+15,500
| New | +$80.8K |
|
|
BZAI
11927
Blaize Holdings
BZAI
$133M
| $80.8K | ﹤0.01% |
23,427
+9,118
| +64% | +$32.4K |
|
11928
PUT
Gerdau
GGB
$10.1B
| $80.6K | ﹤0.01% |
26,000
+11,800
| +83% | +$35.7K |
|
11929
CALL
Lantern Pharma
LTRN
$35.7M
| $80K | ﹤0.01% |
18,400
+2,000
| +12% | +$8.35K |
|
|
NEWP
11930
CALL
New Pacific Metals
NEWP
$1.1B
| $79.9K | ﹤0.01% |
+29,500
| New | +$54.8K |
|
11931
CALL
Nuvation Bio
NUVB
$2.22B
| $79.9K | ﹤0.01% |
21,600
-40,400
| -65% | -$110K |
|
|
OMSE
11932
OMS Energy Technologies
OMSE
$183M
| $79.9K | ﹤0.01% |
+18,804
| New | +$119K |
|
11933
PUT
Annovis Bio
ANVS
$79.6M
| $79.9K | ﹤0.01% |
38,600
+4,700
| +14% | +$11.7K |
|
|
ADAG
11934
Adagene
ADAG
$279M
| $79.8K | ﹤0.01% |
+40,516
| New | +$82.9K |
|
11935
PUT
Hain Celestial
HAIN
$50.3M
| $79.8K | ﹤0.01% |
50,500
+1,500
| +3% | +$2.56K |
|
11936
CALL
Alto Ingredients
ALTO
$392M
| $79.7K | ﹤0.01% |
73,800
-3,300
| -4% | -$3.71K |
|
11937
PUT
Neumora Therapeutics
NMRA
$298M
| $79.5K | ﹤0.01% |
43,700
-10,800
| -20% | -$17.5K |
|
11938
Quest Resource Holding
QRHC
$26.6M
| $79K | ﹤0.01% |
50,626
-3,912
| -7% | -$7.25K |
|
11939
Toro Corp
TORO
$183M
| $79K | ﹤0.01% |
+25,388
| New | +$72.6K |
|
11940
Mobile Infrastructure Corp
BEEP
$86.5M
| $78.8K | ﹤0.01% |
+22,374
| New | +$84.9K |
|
11941
Lesaka Technologies
LSAK
$408M
| $78.8K | ﹤0.01% |
18,977
+3,959
| +26% | +$17.9K |
|
11942
Cardio Diagnostics
CDIO
$5.18M
| $78.7K | ﹤0.01% |
+19,520
| New | +$77.1K |
|
11943
Data Storage Corp
DTST
$7.39M
| $78.6K | ﹤0.01% |
18,199
-15,184
| -45% | -$67.6K |
|
11944
PUT
ADC Therapeutics
ADCT
$136M
| $78.4K | ﹤0.01% |
19,600
+800
| +4% | +$2.52K |
|
11945
Nephros
NEPH
$38.9M
| $78.3K | ﹤0.01% |
16,545
+4,655
| +39% | +$18.3K |
|
|
ADVM
11946
DELISTED
Adverum Biotechnologies
ADVM
| $78.2K | ﹤0.01% |
17,267
-61,004
| -78% | -$180K |
|
|
ADAM
11947
Adamas Trust
ADAM
$848M
| $78.1K | ﹤0.01% |
+11,212
| New | +$77.9K |
|
11948
CALL
Sportsman's Warehouse
SPWH
$46M
| $77.8K | ﹤0.01% |
28,100
-2,100
| -7% | -$6.7K |
|
11949
PUT
Relay Therapeutics
RLAY
$4.29B
| $77.8K | ﹤0.01% |
14,900
-21,200
| -59% | -$80.8K |
|
11950
EUDA Health Holdings
EUDA
$51.5M
| $77.7K | ﹤0.01% |
2,232
+816
| +58% | +$39.6K |
|
Similar funds
Citadel Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Citadel Advisors held 14,587 positions worth $657B, up 14% from $576B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citadel Advisors's Q3 2025 filing shows 2,292 new, 5,365 increased, 4,887 reduced and 1,963 closed positions. Its largest new stake was Permian Resources: 18,381,735 shares worth $235M. The largest sale was Hess, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3.3% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q3 2025 buy was Permian Resources: 18,381,735 shares worth $235M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q3 2025, an estimated $1.45B increase.
- Citadel Advisors's biggest Q3 2025 reduction was McDonald's, cutting an estimated $707M.
- Citadel Advisors fully exited Hess in Q3 2025, selling an estimated $1.24B.
- Citadel Advisors's ten largest holdings make up 25% of its $657B portfolio in Q3 2025.
- Citadel Advisors opened 2,292 new positions and closed 1,963 in Q3 2025.
- Citadel Advisors's portfolio value rose 14% quarter-over-quarter to $657B.
Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.